BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 14697257)

  • 1. p73: in silico evidence for a putative third promoter region.
    Sayan AE; Rossi M; Melino G; Knight RA
    Biochem Biophys Res Commun; 2004 Jan; 313(3):765-70. PubMed ID: 14697257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors.
    Zaika AI; Slade N; Erster SH; Sansome C; Joseph TW; Pearl M; Chalas E; Moll UM
    J Exp Med; 2002 Sep; 196(6):765-80. PubMed ID: 12235210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatiotemporal switch from DeltaNp73 to TAp73 isoforms during nephrogenesis: impact on differentiation gene expression.
    Saifudeen Z; Diavolitsis V; Stefkova J; Dipp S; Fan H; El-Dahr SS
    J Biol Chem; 2005 Jun; 280(24):23094-102. PubMed ID: 15805112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative TP73 transcript analysis in hepatocellular carcinomas.
    Stiewe T; Tuve S; Peter M; Tannapfel A; Elmaagacli AH; Pützer BM
    Clin Cancer Res; 2004 Jan; 10(2):626-33. PubMed ID: 14760085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E1A activates transcription of p73 and Noxa to induce apoptosis.
    Flinterman M; Guelen L; Ezzati-Nik S; Killick R; Melino G; Tominaga K; Mymryk JS; Gäken J; Tavassoli M
    J Biol Chem; 2005 Feb; 280(7):5945-59. PubMed ID: 15572378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of induction of apoptosis by p73 and its relevance to neuroblastoma biology.
    Rossi M; Sayan AE; Terrinoni A; Melino G; Knight RA
    Ann N Y Acad Sci; 2004 Dec; 1028():143-9. PubMed ID: 15650240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo.
    Concin N; Becker K; Slade N; Erster S; Mueller-Holzner E; Ulmer H; Daxenbichler G; Zeimet A; Zeillinger R; Marth C; Moll UM
    Cancer Res; 2004 Apr; 64(7):2449-60. PubMed ID: 15059898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p73 in apoptosis.
    Stiewe T; Pützer BM
    Apoptosis; 2001 Dec; 6(6):447-52. PubMed ID: 11595834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional regulation of the p73 gene by Nrf-2 and promoter CpG methylation in human breast cancer.
    Lai J; Nie W; Zhang W; Wang Y; Xie R; Wang Y; Gu J; Xu J; Song W; Yang F; Huang G; Cao P; Guan X
    Oncotarget; 2014 Aug; 5(16):6909-22. PubMed ID: 25071010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative expression of TAp73 and ΔNp73 isoforms.
    Conforti F; Yang AL; Agostini M; Rufini A; Tucci P; Nicklison-Chirou MV; Grespi F; Velletri T; Knight RA; Melino G; Sayan BS
    Aging (Albany NY); 2012 Mar; 4(3):202-5. PubMed ID: 22388545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A network of p73, p53 and Egr1 is required for efficient apoptosis in tumor cells.
    Yu J; Baron V; Mercola D; Mustelin T; Adamson ED
    Cell Death Differ; 2007 Mar; 14(3):436-46. PubMed ID: 16990849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. deltaNp73 facilitates cell immortalization and cooperates with oncogenic Ras in cellular transformation in vivo.
    Petrenko O; Zaika A; Moll UM
    Mol Cell Biol; 2003 Aug; 23(16):5540-55. PubMed ID: 12897129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative autoregulation of p73 and p53 by DeltaNp73 in regulating differentiation and survival of human neuroblastoma cells.
    Nakagawa T; Takahashi M; Ozaki T; Watanabe K; Hayashi S; Hosoda M; Todo S; Nakagawara A
    Cancer Lett; 2003 Jul; 197(1-2):105-9. PubMed ID: 12880968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TP73, an under-appreciated player in non-Hodgkin lymphoma pathogenesis and management.
    Hassan HM; Dave BJ; Singh RK
    Curr Mol Med; 2014 May; 14(4):432-9. PubMed ID: 24730526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p73 induces apoptosis by different mechanisms.
    Ramadan S; Terrinoni A; Catani MV; Sayan AE; Knight RA; Mueller M; Krammer PH; Melino G; Candi E
    Biochem Biophys Res Commun; 2005 Jun; 331(3):713-7. PubMed ID: 15865927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TP73 allelic expression in human brain and allele frequencies in Alzheimer's disease.
    Li Q; Athan ES; Wei M; Yuan E; Rice SL; Vonsattel JP; Mayeux RP; Tycko B
    BMC Med Genet; 2004 Jun; 5():14. PubMed ID: 15175114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of p63 and p73 expression.
    Waltermann A; Kartasheva NN; Dobbelstein M
    Oncogene; 2003 Aug; 22(36):5686-93. PubMed ID: 12944917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DeltaTAp73 upregulation correlates with poor prognosis in human tumors: putative in vivo network involving p73 isoforms, p53, and E2F-1.
    Domínguez G; García JM; Peña C; Silva J; García V; Martínez L; Maximiano C; Gómez ME; Rivera JA; García-Andrade C; Bonilla F
    J Clin Oncol; 2006 Feb; 24(5):805-15. PubMed ID: 16380414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53.
    Grob TJ; Novak U; Maisse C; Barcaroli D; Lüthi AU; Pirnia F; Hügli B; Graber HU; De Laurenzi V; Fey MF; Melino G; Tobler A
    Cell Death Differ; 2001 Dec; 8(12):1213-23. PubMed ID: 11753569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mdm2-mediated NEDD8 modification of TAp73 regulates its transactivation function.
    Watson IR; Blanch A; Lin DC; Ohh M; Irwin MS
    J Biol Chem; 2006 Nov; 281(45):34096-103. PubMed ID: 16980297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.